Patents Assigned to Nexlmmune, Inc.
  • Publication number: 20160129133
    Abstract: The present invention provides compositions and methods for immunotherapy, which include shelf-stable pharmaceutical compositions for inducing antigen-specific T cells. Such compositions are employed as components of an artificial antigen presenting cell (aAPC), to provide a patient with complexes for presentation of an antigen (e.g., a tumor antigen) and/or a T cell co-stimulatory molecule.
    Type: Application
    Filed: June 23, 2014
    Publication date: May 12, 2016
    Applicant: Nexlmmune, Inc.
    Inventors: Bruce McCreedy, Timothy David Jones, Francis Joseph Carr